[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352207-105":59,"doc-detail-352207-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","single-cell-and-multi-omics-integration-delineates-the-landscape-of-gene-wise-intratumor-heterogeneity-and-identifies-prognostic-biomarkers-for-immunotherapy-in-non-small-cell-lung-cancer","Single-cell and multi-omics integration delineates the landscape of gene-wise intratumor heterogeneity and identifies prognostic biomarkers for immunotherapy in non-small cell lung cancer","","Gene-wise intratumor heterogeneity (ITH) reflects spatial variability in the expression of individual genes across tumor regions, yet remains incompletely mapped in non-small cell lung cancer (NSCLC). Integrating multi-region scRNA-seq with computational variance-and-clustering metrics, the study screens low-ITH genes as immunotherapy predictors and builds the LITHrisk score using immunotherapy RNA-seq and six machine learning algorithms. The resulting low-ITH signature tracks immune pathway activity and immune-cell infiltration, and links key components to immune interaction and microenvironment features.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-and-multi-omics-integration-delineates-the-landscape-of-gene-wise-intratumor-heterogeneity-and-identifies-prognostic-biomarkers-for-immunotherapy-in-non-small-cell-lung-cancer/352207/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-and-multi-omics-integration-delineates-the-landscape-of-gene-wise-intratumor-heterogeneity-and-identifies-prognostic-biomarkers-for-immunotherapy-in-non-small-cell-lung-cancer/352207.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the study define gene-wise intratumor heterogeneity (ITH) in NSCLC?","Question",{"text":113,"@type":114},"ITH is defined as spatial variability in the expression of individual genes across different tumor regions. The work focuses on how immunotherapy-related gene expression varies within tumors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What computational and experimental approach is used to identify prognostic low-ITH genes?",{"text":118,"@type":114},"The study profiles gene-wise ITH using multi-region scRNA-seq data with a computational framework that combines variance and clustering metrics, then screens prognostic low-ITH genes using immunotherapy RNA-seq datasets and six machine learning algorithms to construct the LITHrisk score.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the LITHrisk score and what does it predict?",{"text":122,"@type":114},"The LITHrisk score is a low-ITH-derived gene signature that includes PDL1 and other component genes. It effectively predicts immunotherapy prognosis and response in NSCLC and also across other cancers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352207,1790334953,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Immunology, Immunotherapy (2026) 75:221  \n[https://doi.org/10.1007/s00262-026-04454-4](https://doi.org/10.1007/s00262-026-04454-4)  \nSingle‑cell and multi‑omics integration delineates the landscape of gene‑wise intratumor heterogeneity and identifies prognostic biomarkers for immunotherapy in non‑small cell lung cancer  \nJianye Yuan1 · Zelin Weng2,4 · Zhenguo Li2 · Rui Chen1 · Chao Cheng1 · Weixiong Yang1 · Xiuying Xie2,3,5 · Chang Luo1 · Tao Wang1 · Shuishen Zhang1 · Zihui Tan2,3,5  \nReceived: 4 February 2026 / Accepted: 2 June 2026 © The Author(s) 2026  \nAbstract  \nBackground Gene-wise intratumor heterogeneity (ITH), defined as spatial variability in the expression of individual genes across tumor regions, remains incompletely characterized in non-small cell lung cancer (NSCLC) . Identifying low-ITH genes as predictive biomarkers offers a promising strategy to enhance the reliability of immunotherapy outcome prediction. Methods We profiled gene-wise ITH using multi-region scRNA-seq data and a computational framework combining variance and clustering metrics. Prognostic low-ITH genes were screened via immunotherapy RNA-seq datasets and six machine learning algorithms to construct the LITHrisk score. Transcriptomic profiling and in vitro experiments elucidated the biological and functional relevance of key score components.  \nResults The gene-wise ITH landscape in NSCLC was delineated, with several critical immune checkpoint genes, including PD-L1, LAG3, and TIM-3, being identified as low-ITH genes. A low-ITH-derived signature, the LITHrisk score (PDL1, CDK11B, CXCL13, RPS4Y1, AKR1B10, CRLF1), effectively predicted immunotherapy prognosis and response in NSCLC and other cancers. Tumors with a low LITHrisk score were characterized by enrichment of immune response-related pathways and heightened infiltration of immune cells, such as T cells, B cells, and myeloid cells. Furthermore, we found that component genes of the score were linked to key tumor characteristics: AKR1B10 was associated with tumor immune interactions, functioning via SPP1 regulation to suppress anti-tumor immunity, while CRLF1 was implicated in promoting a fibroblast-enriched microenvironment and modulating tumor cell motility.  \nConclusion Our study provides a practical transcriptome-based tool for advancing precision immunotherapy and nominates potential therapeutic targets for enhancing treatment efficacy.  \nKeywords Gene-wise intratumor heterogeneity · Immunotherapy · Prognostic biomarkers · Non-small cell lung cancer  \nJianye Yuan, Zelin Weng, Zhenguo Li, and Rui Chen have contributed equally to this work.  \n* Jianye Yuan [yuanjy55@mail.sysu.edu.cn](yuanjy55@mail.sysu.edu.cn)  \n* Shuishen Zhang [zhangshsh9@mail.sysu.edu.cn](zhangshsh9@mail.sysu.edu.cn)  \n* Zihui Tan [tanzh@sysucc.org.cn](tanzh@sysucc.org.cn)  \n1 Department of Thoracic Surgery, Sun Yat-Sen University First Affiliated Hospital, Guangzhou, Guangdong, China  \n2 State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China  \nAbbreviations  \nCNV Copy number variation  \nFDR False discovery rate  \n3 Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China  \n4 Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China  \n5 Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, China  \nGEO  \nGSEA  \nICB  \nIHS  \nITH  \nLISI  \nLUAD  \nLUSC  \nNSCLC  \nOS  \nPFS scRNA-seq TCGA  \nUMAP  \nGene expression omnibus  \nGene set enrichment analysis Immune checkpoint blockade Integrated heterogeneity score Intratumor heterogeneity Local inverse Simpson’s index Lung adenocarcinoma  \nLung squamous cell carcinoma Non-small cell lung cancer Overall survival Progression-free survival Single-cell RNA sequencing The cancer genome atlas  \nUniform manifold approximation and projection  \nIntroduction  \nLung cancer continues to impose a","cbCaihKON72LgxXS","https://ap.wps.com/l/cbCaihKON72LgxXS","pdf",11114083,18,"English","# Background\n# Methods\n# Results\n## Low-ITH genes and immune checkpoints\n## LITHrisk score performance and immune features\n# Conclusion","[{\"question\":\"How does the study define gene-wise intratumor heterogeneity (ITH) in NSCLC?\",\"answer\":\"ITH is defined as spatial variability in the expression of individual genes across different tumor regions. The work focuses on how immunotherapy-related gene expression varies within tumors.\"},{\"question\":\"What computational and experimental approach is used to identify prognostic low-ITH genes?\",\"answer\":\"The study profiles gene-wise ITH using multi-region scRNA-seq data with a computational framework that combines variance and clustering metrics, then screens prognostic low-ITH genes using immunotherapy RNA-seq datasets and six machine learning algorithms to construct the LITHrisk score.\"},{\"question\":\"What is the LITHrisk score and what does it predict?\",\"answer\":\"The LITHrisk score is a low-ITH-derived gene signature that includes PDL1 and other component genes. It effectively predicts immunotherapy prognosis and response in NSCLC and also across other cancers.\"}]","Single-cell and multi-omics integration delineates the landscape of gene-wise intratumor heterogeneity and identifies prognostic biomarkers for immunotherapy in non-small cell lung cancer | PDF",1790098302,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6ae67633de1cebdb960121832e593ea.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70d815a66f182958188e5e55bb7d154d.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eebae373f72d0695d8317b8b80447696.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03b6c7359af6b98e92cf05294884492b.webp",980,1301]